We are live on ! Find out more
OPRX icon

OptimizeRx
OPRX

64 hedge funds and large institutions have $109M invested in OptimizeRx in 2019 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 25 increasing their positions, 15 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

133% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 6

67% more repeat investments, than reductions

Existing positions increased: 25 | Existing positions reduced: 15

50% more funds holding in top 10

Funds holding in top 10: 2 → 3 (+1)

14% more funds holding

Funds holding: 56 → 64 (+8)

5.76% more ownership

Funds ownership: 47.58% → 53.34% (+5.8%)

4% more capital invested

Capital invested by funds: $106M → $109M (+$3.84M)

3% less call options, than puts

Call options by funds: $1.24M | Put options by funds: $1.27M

Holders
64
Holders Change
+8
Holders Change %
+14.29%
% of All Funds
1.4%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.07%
New
14
Increased
25
Reduced
15
Closed
6
Calls
$1.24M
Puts
$1.27M
Net Calls
-$34K
Net Calls Change
+$539K

Top Buyers

1
GIPM
G2 Investment Partners Management
New York
+$4.94M
2
BlackRock
BlackRock
New York
+$2.6M
3
CCM
Cadence Capital Management
Massachusetts
+$2.46M
4
TAM
THB Asset Management
Connecticut
+$2.28M
5
Northern Trust
Northern Trust
Illinois
+$2.1M

Top Sellers

1
Marshall Wace
Marshall Wace
United Kingdom
-$1.53M
2
MHP
Manatuck Hill Partners
Connecticut
-$1.38M
3
Russell Investments Group
Russell Investments Group
United Kingdom
-$868K
4
Renaissance Technologies
Renaissance Technologies
New York
-$520K
5
1CM
1492 Capital Management
Wisconsin
-$464K
Name Holding Trade Value Shares
Change 		Change in
Stake
PWAM
1
Park West Asset Management
California
$15.6M -$139K -8,952 -0.8%
BlackRock
2
BlackRock
New York
$11.2M +$2.6M +168,223 +28%
GIPM
3
G2 Investment Partners Management
New York
$9.62M +$4.94M +319,212 +93%
WAM
4
Wolverine Asset Management
Illinois
$9.43M -$369K -23,844 -4%
Vanguard Group
5
Vanguard Group
Pennsylvania
$8.53M +$1.21M +78,057 +15%
WA
6
Wasatch Advisors
Utah
$5.61M -$272K -17,581 -4%
Calamos Advisors
7
Calamos Advisors
Illinois
$4.53M +$705K +45,548 +17%
1CM
8
1492 Capital Management
Wisconsin
$3.41M -$464K -29,956 -11%
State Street
9
State Street
Massachusetts
$3.35M +$961K +62,105 +37%
AC
10
Avenir Corporation
Virginia
$3.25M – – –
VCM
11
Venator Capital Management
Ontario, Canada
$2.92M -$189K -12,200 -6%
Russell Investments Group
12
Russell Investments Group
United Kingdom
$2.88M -$868K -56,083 -22%
PCM
13
Perkins Capital Management
Minnesota
$2.69M -$417K -26,970 -13%
Northern Trust
14
Northern Trust
Illinois
$2.64M +$2.1M +135,873 +291%
MHP
15
Manatuck Hill Partners
Connecticut
$2.33M -$1.38M -89,100 -36%
CCM
16
Cadence Capital Management
Massachusetts
$2.3M +$2.46M +159,072 New
Geode Capital Management
17
Geode Capital Management
Massachusetts
$2.28M +$269K +17,402 +12%
TAM
18
THB Asset Management
Connecticut
$2.14M +$2.28M +147,557 New
DCM
19
Driehaus Capital Management
Illinois
$1.53M +$314K +20,300 +24%
TWMP
20
Taylor Wealth Management Partners
Massachusetts
$1.49M -$2.94K -190 -0.2%
RHJA
21
Rice Hall James & Associates
California
$1.22M +$1.31M +84,345 New
William Blair & Company
22
William Blair & Company
Illinois
$1.2M +$103K +6,625 +9%
OAM
23
Oberweis Asset Management
Illinois
$746K +$224K +14,500 +39%
Fifth Third Bancorp
24
Fifth Third Bancorp
Ohio
$743K – – –
N
25
Nuveen
North Carolina
$595K +$153K +9,865 +32%
1
2 3

OPRX Hedge Fund Activity: Q3 2019 in Review

64 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in OptimizeRx (OPRX) for Q3 2019, worth a combined $109M — up 3.6% from $106M a quarter earlier.

Buyers outnumbered sellers: 14 funds opened new OPRX positions and 6 closed out — a net gain of 8 holders — while 25 added to existing stakes and 15 trimmed.

The largest buyer was G2 Investment Partners Management, adding an estimated $4.94M. The largest seller was Marshall Wace, exiting entirely with an estimated $1.53M sold.

  • 64 institutional investors held OptimizeRx (OPRX) as of Q3 2019, up from 56 in Q2 2019.
  • Funds reported $109M of OptimizeRx stock for Q3 2019, up 3.6% quarter-over-quarter.
  • 14 funds opened new OptimizeRx positions in Q3 2019 and 6 closed out, a net change of +8 holders.
  • The largest OptimizeRx buyer in Q3 2019 was G2 Investment Partners Management, an estimated $4.94M added.
  • The largest OptimizeRx seller in Q3 2019 was Marshall Wace, an estimated $1.53M sold.

Based on aggregated 13F filings for Q3 2019.